Skip to main content

Table 3 Risk factor analysis for in-hospital mortality of ECMO patients

From: Cross-sectional study for the clinical application of extracorporeal membrane oxygenation in Mainland China, 2018

Factors All
OR 95% CI P
Type (Ref = VA)
 VV 0.95 0.75 1.19 0.6431
Age (Ref = 0–13)
 14–20 1.11 0.62 1.98 0.7255
 21–30 0.84 0.52 1.35 0.4699
 31–40 0.80 0.50 1.27 0.3469
 41–50 0.87 0.56 1.34 0.5280
 51–60 1.13 0.74 1.71 0.5823
 61–70 1.12 0.74 1.70 0.5782
  > 71 1.61 1.01 2.55 0.0452
Sex (Ref = male)
 Female 0.80 0.65 0.99 0.0400
GDP (Ref = high)
 Middle 0.72 0.56 0.93 0.0110
 Low 1.19 0.86 1.66 0.3017
Season (Ref = spring)
 Summer 1.35 1.01 1.81 0.0420
 Autumn 0.92 0.69 1.22 0.5658
 Winter 1.10 0.84 1.46 0.4858
Diagnosis at discharge
 Infectious disease 1.01 0.79 1.29 0.9584
 Blood system disease 1.29 1.01 1.65 0.0413
 Endocrine disease 1.18 0.96 1.46 0.1221
 CNS disease 1.85 1.40 2.43 < 0.0001
 Circulatory disease
 Respiratory disease
 Digestive disease 1.10 0.88 1.38 0.3953
 Urogenital diseases 1.04 0.83 1.31 0.7348
Congenital malformations 1.59 1.08 2.33 0.0180
Injury and poisoning 1.12 0.83 1.52 0.4607
  1. ECMO extracorporeal membrane oxygenation, VV veno-venous, VA veno-arterial, OR odd ration, 95%CI 95% confidence interval, GDP gross domestic product, CNS disease central nervous disease